Placeholder Banner

Statement Regarding Interactions With Healthcare Professionals

February 19, 2009

Statement regarding Interactions with Healthcare Professionals

BIO and our member companies remain dedicated to the improvement of patient care and the advancement of medical science.  In pursuing this mission, we recognize that adherence to strict ethical standards and compliance with applicable laws is critical to our industry’s ability to continue our collaboration with healthcare professionals and maintain the trust of our patients.  For these reasons, BIO supports the principles in PhRMA’s Code governing interactions with healthcare professionals, and will continue to encourage its members to maintain the highest standards for ethical business practices and socially responsible industry conduct related to company interactions with healthcare professionals.

Specifically, BIO encourages each of its member companies that are involved in the marketing of biologics or other pharmaceuticals to United States healthcare professionals to adopt a transparent and rigorous code of conduct, such as the PhRMA Code, tailored as appropriate to its own particular circumstances and which also ensures compliance with all applicable local, state, and federal laws and regulations.  BIO members that wish to sign on to the PhRMA Code may do so, even if they are not PhRMA members.

 

Discover More
WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), released the following statement on passage of the One, Big, Beautiful Bill Act (OBBBA):“The OBBBA contains important bipartisan provisions…
Annual award honors governors for their leadership and commitment to strengthening biotechnology in their state BOSTON (June 17, 2025) – Today, the Biotechnology Innovation Organization (BIO) named Massachusetts Governor Maura Healey…
Industry veteran takes the helm as Dr. Ted Love concludes two-year term marked by strategic growth and transition BOSTON (June 16, 2025) – Today, the Biotechnology Innovation Organization (BIO) announced that Fritz Bittenbender,…